undamentalytics Newsletter

Airsculpt Technologies, Inc. income statement

In fiscal 2025, Airsculpt Technologies, Inc. reported revenue of $152m, down 15.8% on the year before, operating income of −$11.6m (a -7.6% margin) and net income of −$11.7m, or −$0.19 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Airsculpt Technologies, Inc.: income statement, annual
Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4163133169196180152151
Selling, general and administrative202466101102998284
Operating income11016−510−2−12−13
Interest expense32576665
Income before tax−2811−113−8−18−18
Income tax000370−6−6
Net income−2811−15−4−8−12−12
Diluted EPS——−$0.01−$0.26−$0.08−$0.14−$0.19−$0.18
Diluted shares (average)——56m56m57m58m60m66m
EBITDA61622420101−0

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AIRS vs NRCAIRS vs PETSAIRS vs RDGTAIRS vs SBC

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Airsculpt Technologies, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Airsculpt Technologies, Inc.